Submitted by ETC Staff on
RAFI Follows the Money
Before disclosing the cloning breakthrough, patent applications were filed and research papers prepared for publication. PPL Therapeutics, a small biotechnology company will be assigned the patent. After the cloning announcement, shares of PPL Therapeutics jumped 16% in one day on the London Stock Exchange.
| Attachment | Size |
|---|---|
 Download File | 0 bytes |